STAT October 10, 2018
STAT reporter Casey Ross leads a thought provoking conversation with key industry experts about how drug developers, doctors, and bioinformatics researchers are using artificial intelligence to revolutionize the search for breakthrough therapies.
If a group of chemists found 18 more potent versions of a drug out of a sea of 3,000 potential chemicals in the span of a few weeks, they might be hailed as superhumans.
That actually happened at Relay Therapeutics, said Dr. Donald Bergstrom, the company’s head of R&D. But the driving force behind it wasn’t human at all — it was artificial intelligence.
AI and machine learning have been hailed as a powerful new tool for drug discovery. But despite the hype, there is still a huge...
Today's Sponsors
Today's Sponsor